BQ-123
- Generic Name
- BQ-123
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H42N6O7
- CAS Number
- 136553-81-6
- Unique Ingredient Identifier
- S2A8YZM151
- Background
BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.
- Associated Conditions
- -
- Associated Therapies
- -
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- The University of Texas at Arlington
- Target Recruit Count
- 19
- Registration Number
- NCT03679780
- Locations
- 🇺🇸
Science and Engineering Research and Innovation Building, Arlington, Texas, United States
: Vascular Function in Health and Disease
- Conditions
- Interventions
- First Posted Date
- 2016-11-17
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Russell Richardson
- Target Recruit Count
- 420
- Registration Number
- NCT02966665
- Locations
- 🇺🇸
George E Wahlen VA Medical Center, Salt Lake City, Utah, United States
Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2021-12-20
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 30
- Registration Number
- NCT02124824
- Locations
- 🇺🇸
VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States
Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
- Conditions
- Interventions
- First Posted Date
- 2012-08-07
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 120
- Registration Number
- NCT01658410
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Role of Endothelin-1 in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans
- Conditions
- Interventions
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2012-08-10
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 16
- Registration Number
- NCT00915070
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
The Role of Endothelin in Pulmonary Hypertension
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2018-11-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT00759408
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 23
- Registration Number
- NCT00586820
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 57
- Registration Number
- NCT00502528
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Vienna-Austria, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.